Author:
Herbort Carl P.,Abu El Asrar Ahmed M.,Takeuchi Masuru,Pavésio Carlos E.,Couto Cristobal,Hedayatfar Alireza,Maruyama Kazuichi,Rao Xi,Silpa-archa Sukhum,Somkijrungroj Thanapong
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Emery P, Seto Y (2003) Role of biologics in early arthritis. Clin Exp Rheumatol 21(Suppl 31):S191–S194
2. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS (2004) Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 43:906–914
3. Finckh A, Liang MH, van Herckenrode CM, de Pablo P (2006) Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 55:864–872
4. van Nies JA, Krabben A, Schoones JW, Huizinga TW, Kloppenburg M, van der Helm-van Mil AH (2014) What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis 73:861–870
5. Gocho K, Kondo I, Yamaki K (2001) Identification of autoreactive T cells in Vogt–Koyanagi–Harada disease. Invest Ophthalmol 42:2004–2009
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献